Microbiome-Driven Therapeutics: From Gut Health to Precision Medicine
Терапевтические подходы на основе микробиома: от здоровья кишечника к прецизионной медицине
2025-01-15
SCID: 54.1/8swh3uwt
Discuss with AI
fecal microbiota transplantationgut microbiomemetagenomic profilingmicrobiome-driven therapeuticsprecision medicine
Figures from the paper
Abstract (AI)
The human microbiome, a complex ecosystem of microorganisms residing in and on the body, plays a pivotal role in regulating a wide range of physiological processes, including digestion, immune responses, and metabolic functions. In recent years, the rapidly growing field of microbiome-driven therapeutics has garnered significant attention for its potential to revolutionize healthcare. This review explores the evolving landscape of microbiome-based therapies, with a particular focus on the gut microbiome and its implications for both gut health and precision medicine. We highlight recent advances in understanding how microbial communities influence disease pathogenesis and treatment outcomes, spanning conditions such as inflammatory bowel disease (IBD), metabolic disorders, neurological diseases, and even cancer. This article also discusses emerging therapeutic strategies, including probiotics, prebiotics, fecal microbiota transplantation (FMT), and microbial-based drugs, as well as the challenges associated with their clinical implementation. Additionally, we examined how the integration of microbiome profiling and metagenomic data is advancing the field of precision medicine, paving the way for more personalized and effective treatments. This review serves as a comprehensive resource that synthesizes current knowledge, identifies key gaps in microbiome research, and offers insights into the future direction of microbiome-driven therapeutics, thus providing a valuable framework for clinicians, researchers, and policymakers seeking to harness the potential of the microbiome to advance personalized healthcare solutions.
Key Findings
1
Integrating microbiome profiling with metagenomic data is advancing precision medicine by supporting more personalized and potentially effective treatments.
2
Microbial communities influence disease pathogenesis and treatment outcomes across inflammatory bowel disease, metabolic, neurological, and cancer-related conditions.
3
Microbiome-based strategies include probiotics, prebiotics, fecal microbiota transplantation, and microbial-based drugs, but clinical implementation remains challenging.
4
The human microbiome regulates digestion, immune responses, and metabolic functions, making it a potential therapeutic target.
5
The review synthesizes current knowledge, identifies persistent research gaps, and outlines future directions for microbiome-driven therapeutics.
Research Object
the human gut microbiome
Research Subject
its influence on disease pathogenesis and treatment outcomes, and its therapeutic and precision-medicine applications
Publication Details
Publication Date
2025-01-15
Journal
Publisher
ISSN
Cited by
97
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
Interaction between microbiota and immunity in health and disease2020
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health2017
The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?2020
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review2023